The efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A Chinese multicenter real-world study

BACKGROUND: Patients with extensive-stage small-cell lung cancer (ES-SCLC) have high recurrence rates and bleak prognosis. This multicenter real-world study aimed to explore the efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as the first-line treatment of ES-SCLC. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hao-Ran, Jiang, Ai-Min, Gao, Huan, Liu, Na, Zheng, Xiao-Qiang, Fu, Xiao, Ruan, Zhi-Ping, Tian, Tao, Liang, Xuan, Yao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531009/
https://www.ncbi.nlm.nih.gov/pubmed/36203439
http://dx.doi.org/10.3389/fonc.2022.894835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531009/
https://www.ncbi.nlm.nih.gov/pubmed/36203439
http://dx.doi.org/10.3389/fonc.2022.894835

Ejemplares similares